HLA-G and anti-HCV in patients on the waiting list for kidney transplantation

Curigliano, 2013, Molecular pathways: human leukocyte antigen G (HLA-G), Clin Cancer Res, 19, 5564, 10.1158/1078-0432.CCR-12-3697 Zullo, 2017, Epigenetics and type 1 diabetes: mechanisms and translational applications, Transl Res, 185, 85, 10.1016/j.trsl.2017.05.002 Sommese, 2017, Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus, Epigenetics, 12, 401, 10.1080/15592294.2016.1278097 Grimaldi, 2017, Evidence of epigenetic tags in cardiac fibrosis, J Cardiol, 69, 401, 10.1016/j.jjcc.2016.10.004 Napoli, 2016, Novel epigenetic-based therapies useful in cardiovascular medicine, World J Cardiol, 8, 211, 10.4330/wjc.v8.i2.211 Picascia, 2015, Innate and adaptive immune response in stroke: focus on epigenetic regulation, J Neuroimmunol, 289, 111, 10.1016/j.jneuroim.2015.10.013 Tilburgs, 2015, The HLA-G cycle provides for both NK tolerance and immunity at the maternal-fetal interface, Proc Natl Acad Sci U S A, 112, 13312, 10.1073/pnas.1517724112 Gao, 2000, Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8 alpha-alpha, J Biol Chem, 275, 15232, 10.1074/jbc.275.20.15232 Larsen, 2009, Human leukocyte antigen-G polymorphism in relation to expression, function, and disease, Hum Immunol, 70, 1026, 10.1016/j.humimm.2009.07.015 Rizzo, 2009, Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy, Am J Reprod Immunol, 62, 320, 10.1111/j.1600-0897.2009.00742.x Rouas-Freiss, 1997, Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis, Proc Natl Acad Sci U S A, 94, 11520, 10.1073/pnas.94.21.11520 Agaugué, 2011, Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17, Blood, 117, 7021, 10.1182/blood-2010-07-294389 Dias, 2015, The role of HLA-G molecule and HLA-G gene polymorphisms in tumors, viral hepatitis, and parasitic diseases, Front Immunol, 2, 9 Amiot, 2015, Biology of the immunomodulatory molecule HLA-G in human liver diseases, J Hepatol, 62, 1430, 10.1016/j.jhep.2015.03.007 Shi, 2011, Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection, Hum Immunol, 72, 1068, 10.1016/j.humimm.2011.06.012 Weng, 2011, Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection, Hum Immunol, 72, 406, 10.1016/j.humimm.2011.02.008 Fallahi, 2012, Cytokines and HCV-related disorders, Clin Dev Immunol, 2012, 468107, 10.1155/2012/468107 Couper, 2008, IL-10: the master regulator of immunity to infection, J Immunol, 180, 5771, 10.4049/jimmunol.180.9.5771 Amiot, 2014, Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis, J Hepatol, 60, 245, 10.1016/j.jhep.2013.09.006 De Oliveira Crispim, 2012, Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infection, Hum Immunol, 73, 258, 10.1016/j.humimm.2011.12.004 Fainardi, 2011, Emerging topics and new perspectives on HLA-G, Cell Mol Life Sci, 68, 433, 10.1007/s00018-010-0584-3 Carosella, 2008, HLA-G: from biology to clinical benefits, Trends Immunol, 29, 125, 10.1016/j.it.2007.11.005 Ezeakile, 2014, HLA-G dimers in the prolongation of kidney allograft survival, J Immunol Res, 2014, 153981, 10.1155/2014/153981 Li, 2009, HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells, Proc Natl Acad Sci U S A, 106, 5767, 10.1073/pnas.0901173106 Carosella, 2015, HLA-G: an immune checkpoint molecule, Adv Immunol, 127, 33, 10.1016/bs.ai.2015.04.001 Žilinská, 2015, Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients, Transpl Immunol, 33, 159, 10.1016/j.trim.2015.10.001 Poláková, 2015, Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients, Immunobiology, 220, 533, 10.1016/j.imbio.2014.10.017 Zarkhin, 2010, Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients, Transplantation, 90, 1000, 10.1097/TP.0b013e3181f546af Rebmann, 2009, Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation, Hum Immunol, 70, 995, 10.1016/j.humimm.2009.07.016 Xiao, 2013, HLA-G expression in the peripheral blood of live kidney transplant recipients, Chin Med J (Engl), 126, 2652 Sommese, 2014, Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems, Scand J Infect Dis, 46, 660, 10.3109/00365548.2014.926564 Sommese, 2014, Comparison between screening and confirmatory serological assays in blood donors in a region of South Italy, J Clin Lab Anal, 28, 198, 10.1002/jcla.21666 Lila, 2002, Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection, Circulation, 105, 1949, 10.1161/01.CIR.0000015075.89984.46 Rudstein-Svetlicky, 2006, HLA-G levels in serum and plasma, Tissue Antigens, 67, 111, 10.1111/j.1399-0039.2006.00540.x Apps, 2008, A critical look at HLA-G, Trends Immunol, 29, 313, 10.1016/j.it.2008.02.012 Zaza, 2013, A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients, BMC Med Genomics, 6, 17, 10.1186/1755-8794-6-17 Moreau, 2003, HLA-G gene repression is reversed by demethylation, Proc Natl Acad Sci U S A, 100, 1191, 10.1073/pnas.0337539100 Kanwal, 2015, Cancer epigenetics: an introduction, Methods Mol Biol, 1238, 3, 10.1007/978-1-4939-1804-1_1